Aptadir Therapeutics

Healthcare & Life Sciences

Recent Finacing

Recent Raise

Aptadir Therapeutics is a biotech company developing RNA-based inhibitors to treat Myelodysplastic Syndrome (MDS).

Total Funding

Headquarters

Founded

Website

Focus Areas

biotech

Myelodysplastic Syndrome

RNA inhibitors

DNMTs Interacting RNAs

therapeutic approaches

Investors